Literature DB >> 9274485

Iron and hepatitis C.

B R Bacon1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274485      PMCID: PMC1027241          DOI: 10.1136/gut.41.1.127

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  11 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

Authors:  J K Olynyk; K R Reddy; A M Di Bisceglie; L J Jeffers; T I Parker; J L Radick; E R Schiff; B R Bacon
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

3.  Measurements of iron status in patients with chronic hepatitis.

Authors:  A M Di Bisceglie; C A Axiotis; J H Hoofnagle; B R Bacon
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C.

Authors:  A Piperno; M Sampietro; R D'Alba; L Roffi; S Fargion; S Parma; C Nicoli; N Corbetta; M Pozzi; V Arosio; G Boari; G Fiorelli
Journal:  Liver       Date:  1996-08

5.  Letter: Elevated serum iron levels and persistent Australia antigen (HBsAG).

Authors:  A I Sutnick; B S Blumberg; E D Lustbader
Journal:  Ann Intern Med       Date:  1974-12       Impact factor: 25.391

6.  Iron reduction therapy: simply camouflage, or a real weapon?

Authors:  P Caraceni; S Fagiuoli; D H Van Thiel
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

7.  Serum ferritin as a predictor of host response to hepatitis B virus infection.

Authors:  E D Lustbader; H W Hann; B S Blumberg
Journal:  Science       Date:  1983-04-22       Impact factor: 47.728

8.  Serum ferritin in patients with iron overload and with acute and chronic liver diseases.

Authors:  J Prieto; M Barry; S Sherlock
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

9.  Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.

Authors:  H Hayashi; T Takikawa; N Nishimura; M Yano; T Isomura; N Sakamoto
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

10.  Response to interferon alpha therapy is influenced by the iron content of the liver.

Authors:  D H Van Thiel; L Friedlander; S Fagiuoli; H I Wright; W Irish; J S Gavaler
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083

View more
  1 in total

1.  Hepatic iron quantitation and its relationship with disease measures and histologically assessed iron content.

Authors:  Shabbar Sajjad; Moises Garcia; Ahmed Malik; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.